Serge Danhier

Caen, 14000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14).

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14).

Journal: Current oncology (Toronto, Ont.)

Published: September 16, 2021

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.

Journal: BMC cancer

Published: May 27, 2019

Decision making factors of the management of ductal carcinoma in situ of the breast with microinvasion

Decision making factors of the management of ductal carcinoma in situ of the breast with microinvasion

Journal: Bulletin du cancer

Published: December 07, 2018

Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC.

Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC.

Journal: Cancer medicine

Published: August 13, 2018

Cardiac complications of breast radiation therapy

Cardiac complications of breast radiation therapy

Journal: Bulletin du cancer

Published: May 25, 2018

Radiation therapy in inflammatory breast cancer

Radiation therapy in inflammatory breast cancer

Journal: Bulletin du cancer

Published: September 14, 2017

Proton therapy for locally advanced breast cancer: A systematic review of the literature.

Proton therapy for locally advanced breast cancer: A systematic review of the literature.

Journal: Cancer treatment reviews

Published: September 13, 2017

Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer.

Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer.

Journal: The American journal of case reports

Published: August 16, 2017

Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.

Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 10, 2017

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 08, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026